+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pen Needles Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

  • PDF Icon

    Report

  • 141 Pages
  • November 2023
  • Region: Global
  • IMARC Group
  • ID: 5911914

Quick Summary:

In the landscape of healthcare innovation, the global pen needles market commands attention for its pivotal role in patient care management. Coupled with technological advancements and a pressing need for efficient drug delivery systems, pen needles have emerged as a cornerstone in the treatment of various chronic conditions. They offer a seamless balance of convenience and precision, vital for diagnostics and therapeutic interventions that influence the quality of life for millions of patients globally.

With this comprehensive market research report, industry leaders and decision-makers will gain an unparalleled overview of the pen needles market. The report dissects critical trends that shape the industry, presents an in-depth analysis of current and emerging market segments, and offers strategic insights into regional market dynamics. The report is an indispensable asset for executives aiming to navigate this market with informed confidence, construct robust business strategies, and identify opportunities for investment or expansion.

The global pen needles market size reached US$ 3.3 Billion in 2022. Looking forward, the market is expected to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 14.41% during 2022-2028.

Pen needles are disposable hollow needles used in pen injectors for delivering pharmaceutical drugs in the subcutaneous tissues of the body. The needle is fixed in the plastic hub of the medical injector pen and consists of plastic caps and individual wrapping for enhanced security and sterilization. Pen needles are manufactured using electro-polishing techniques to achieve smooth, fine and thin point tips for convenient penetration. They are available in a wide variety of gauge sizes and lengths and are majorly used by diabetic patients that require multiple dosages of insulin injections every day. In comparison to the traditionally used syringes and vials, pen needles are highly cost-effective, convenient to use, portable and do not require refrigeration.

Pen Needles Market Trends

The increasing prevalence of diabetes mellitus (DM) and other chronic medical disorders, such as osteoporosis, cardiovascular disease (CVD) and multiple sclerosis, is one of the key factors driving the growth of the market. The treatment of these ailments require multidrug regimen that involves daily or weekly administration of medicinal drugs with injector pens. Moreover, the rising geriatric population, which is more susceptible to chronic ailments is contributing to the growth of the market. Insulin pens provide a reliable, accurate and simplified dosing solution to the elderly patients and facilitate self-administration. Additionally, various product innovations, such as the development of ultra-thin and short-length needles with improved drug delivery systems, are acting as other growth-inducing factors. The traditionally used needles were difficult to use during self-dosage and caused more pain and discomfort to the patients. Other factors, including the increasing healthcare expenditure capacities of the masses, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.

Key Market Segmentation

This research provides an analysis of the key trends in each sub-segment of the global pen needles market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on type, needle length, therapy, mode of purchase and end user.

Breakup by Type:

  • Standard Pen Needles
  • Safety Pen Needles

Breakup by Needle Length:

  • 4mm
  • 5mm
  • 6mm
  • 8mm
  • 10mm
  • 12mm

Breakup by Therapy:

  • Insulin
  • GLP-1
  • Growth Hormones

Breakup by Mode of Purchase:

  • Retail
  • Non-Retail

Breakup by End User:

  • Hospitals and Clinics
  • Home Healthcare

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Latin America
  • Brazil
  • Mexico
  • Middle East and Africa

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players being A. Menarini Diagnostics srl, Advancare Pharma, Arkray Inc., B. Braun Melsungen AG, Becton Dickinson and Company, Hindustan Syringes & Medical Devices Ltd., HTL Strefa SA, Novo Nordisk A/S, Owen Mumford Ltd., Simple Diagnostics, Trividia Health Inc. (Sinocare) and Ultimed Inc.

Key Questions Answered in This Report

1. What was the size of the global pen needles market in 2022?
2. What is the expected growth rate of the global pen needles market during 2023-2028?
3. What are the key factors driving the global pen needles market?
4. What has been the impact of COVID-19 on the global pen needles market?
5. What is the breakup of the global pen needles market based on the type?
6. What is the breakup of the global pen needles market based on the needle length?
7. What is the breakup of the global pen needles market based on the therapy?
8. What is the breakup of the global pen needles market based on the mode of purchase?
9. What is the breakup of the global pen needles market based on the end user?
10. What are the key regions in the global pen needles market?
11. Who are the key players/companies in the global pen needles market?
Frequently Asked Questions about the Global Pen Needles Market

What is the estimated value of the Global Pen Needles Market?

The Global Pen Needles Market was estimated to be valued at $3.3 Billion in 2022.

What is the growth rate of the Global Pen Needles Market?

The growth rate of the Global Pen Needles Market is 14.4%, with an estimated value of $7.4 Billion by 2028.

What is the forecasted size of the Global Pen Needles Market?

The Global Pen Needles Market is estimated to be worth $7.4 Billion by 2028.

Who are the key companies in the Global Pen Needles Market?

Key companies in the Global Pen Needles Market include ABB Ltd., F&P Robotics AG, Fanuc Corporation, Hanson Robotics Limited, Honda Motor Co. Ltd, iRobot Corporation, KUKA AG (Midea Group), Neato Robotics Inc. (Vorwerk), Rethink Robotics GmbH and Samsung Electronics Co. Ltd..

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Pen Needles Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Standard Pen Needles
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Safety Pen Needles
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Needle Length
7.1 4mm
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 5mm
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 6mm
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 8mm
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 10mm
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 12mm
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by Therapy
8.1 Insulin
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 GLP-1
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Growth Hormones
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Mode of Purchase
9.1 Retail
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Non-Retail
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by End User
10.1 Hospitals and Clinics
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Home Healthcare
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 A. Menarini Diagnostics srl
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Advancare Pharma
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Arkray Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 B. Braun Melsungen AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 SWOT Analysis
16.3.5 Becton Dickinson and Company
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Hindustan Syringes & Medical Devices Ltd.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 HTL Strefa S A
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Novo Nordisk
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Owen Mumford Ltd.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 SWOT Analysis
16.3.10 Simple Diagnostics
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Trividia Health Inc. (Sinocare)
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Ultimed Inc.
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio

Companies Mentioned

  • A. Menarini Diagnostics srl
  • Advancare Pharma
  • Arkray Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Company
  • Hindustan Syringes & Medical Devices Ltd.
  • HTL Strefa SA
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Simple Diagnostics
  • Trividia Health Inc. (Sinocare)
  • Ultimed Inc.

Methodology

Loading
LOADING...